These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1376830

  • 1. Platelet activation by low-density lipoprotein and serotonin: effects of calcium antagonists.
    Fetkovska N.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S25-8. PubMed ID: 1376830
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of thrombocyte activity in atherogenesis and thrombogenesis using isradipine and other calcium antagonists].
    Fet'kovská N, Ulicná L, Jakubovská Z.
    Vnitr Lek; 1993 Apr; 39(4):326-33. PubMed ID: 8351859
    [Abstract] [Full Text] [Related]

  • 3. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N, Sebekova K, Fedelesova V, Dzurik R.
    J Cardiovasc Pharmacol; 1991 Apr; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [Abstract] [Full Text] [Related]

  • 4. Platelet serotonin-LDL interaction in essential hypertension.
    Amstein R, Fetkovska N, Bühler FR.
    J Cardiovasc Pharmacol; 1991 Apr; 17 Suppl 5():S35-40. PubMed ID: 1717771
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.
    Fetkovská N, Fedelesová V, Kozlovský M, Dzúrik R.
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):175S-177S. PubMed ID: 1827014
    [Abstract] [Full Text] [Related]

  • 6. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA, Batey AJ, Coker SJ.
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [Abstract] [Full Text] [Related]

  • 7. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
    Ding YA, Han CL, Chou TC, Lai WY, Shiao MF.
    J Cardiovasc Pharmacol; 1992 Jul; 19 Suppl 3():S32-7. PubMed ID: 1376832
    [Abstract] [Full Text] [Related]

  • 8. Inhibitor analysis of LDL-induced platelet aggregation.
    Vlasova II, Azizova OA, Lopukhin YuM.
    Biochemistry (Mosc); 1997 Mar; 62(3):307-11. PubMed ID: 9275303
    [Abstract] [Full Text] [Related]

  • 9. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z, Liu B, Zhou J, Zhang Z, Liu Y, Bai H.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [Abstract] [Full Text] [Related]

  • 10. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
    Ivleva AIa, Kobalava ZhD, Moiseev VS.
    Farmakol Toksikol; 1989 Oct; 52(2):77-80. PubMed ID: 2568273
    [Abstract] [Full Text] [Related]

  • 11. [Calcium channel blockers inhibit human low-density lipoprotein peroxidation induced by oxygen free radicals in vitro].
    Napoli C, Ambrosio G, Palumbo G, Chiariello P, Chiariello M.
    Cardiologia; 1992 Nov; 37(11):801-4. PubMed ID: 1298553
    [Abstract] [Full Text] [Related]

  • 12. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
    Li BY, Zhou YC, Li WH.
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
    [Abstract] [Full Text] [Related]

  • 13. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro.
    Wang LL, Mei QB, Zhao DH, Guo ZA.
    Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY, Bai Y, Li WH.
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [Abstract] [Full Text] [Related]

  • 15. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T, Morishima Y, Watanabe K, Takahashi M, Shibano T.
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [Abstract] [Full Text] [Related]

  • 16. Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein.
    Cox DA, Cohen ML.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1095-103. PubMed ID: 8786540
    [Abstract] [Full Text] [Related]

  • 17. [Calcium antagonists: anti-atherosclerotic effect by modification of the prostaglandin system].
    Weiss K.
    Wien Klin Wochenschr; 1988 Nov 04; 100(21):718-20. PubMed ID: 3071922
    [Abstract] [Full Text] [Related]

  • 18. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):513-7. PubMed ID: 6314581
    [Abstract] [Full Text] [Related]

  • 19. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
    Wang W, Wang YP, Sun WK, Xu YM, Xuan LJ.
    Acta Pharmacol Sin; 2000 Sep 30; 21(9):859-63. PubMed ID: 11501172
    [Abstract] [Full Text] [Related]

  • 20. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II, Vakhrusheva TV, Azizova OA, Lopukhin IuM.
    Vopr Med Khim; 1998 Sep 30; 44(1):43-54. PubMed ID: 9575612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.